Evidence map›Paper›PMID 30449621›Full record

ArticleCell2018

Acetylation of Cytidine in mRNA Promotes Translation Efficiency.

Daniel Arango, David Sturgill, Najwa Alhusaini, Allissa A Dillman, Thomas J Sweet, Gavin Hanson, Masaki Hosogane, Wilson R Sinclair, Kyster K Nanan, Mariana D Mandler and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 548 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
548citing papers in PubMed, 1 pooled it
20.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

548 citing papers in PubMed, 1 synthesis or guideline pooled it, 835 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Nat10-mediated acScience China. Life sciences · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Compendium of RNA modifications for bacterial stress adaptation.Microbiology and molecular biology reviews : MMBR · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Beyond mBiomedicines · 2026
    Review
  17. Article
  18. Review
  19. Innate immunity: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  20. Review

488 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Daniel ArangoLaboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
David SturgillLaboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Najwa AlhusainiCenter for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, OH 44106, USA.
Allissa A DillmanLaboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Thomas J SweetCenter for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, OH 44106, USA.
Gavin HansonCenter for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, OH 44106, USA.
Masaki HosoganeLaboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Wilson R SinclairChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD 21702, USA.
Kyster K NananLaboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Mariana D MandlerLaboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Stephen D FoxProtein Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA.
Thomas T ZengeyaChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD 21702, USA.
Thorkell AndressonProtein Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA.
Jordan L MeierChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD 21702, USA.
Jeffery CollerCenter for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, OH 44106, USA.
Shalini OberdoerfferLaboratory of Receptor Biology and Gene Expression, National Cancer Institute, NIH, Bethesda, MD 20892, USA. Electronic address: shalini.oberdoerffer@nih.gov.
National Cancer Institute · USCase Western Reserve University · USCenter for Cancer Research · USFrederick National Laboratory for Cancer Research · USLeidos Biomedical Research Inc. (United States)

Funding

Impact of chromatin structure on alternative splicing of CD45 pre-mRNAZIABC011293 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI OBERDOERFFER, SHALINI · 2010 to 2025
$22.2M
Targeting Cancer Through Modifications and MetabolismZIABC011488 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MEIER, JORDAN L · 2013 to 2025
$21.3M
Understanding the Interconnection Between mRNA turnover and mRNA TranslationR01GM125086 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI COLLER, JEFFERY · 2017 to 2020
$1.6M
Determining the influence of codon optimality on mRNA translation and decayR01GM118018 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI COLLER, JEFFERY · 2017 to 2020
$1.3M
Intramural NIH HHS ZIA BC011293NIGMS NIH HHS R01 GM118018NIGMS NIH HHS R01 GM125086
6 · The paper itself

Abstract

Generation of the "epitranscriptome" through post-transcriptional ribonucleoside modification embeds a layer of regulatory complexity into RNA structure and function. Here, we describe N4-acetylcytidine (ac4C) as an mRNA modification that is catalyzed by the acetyltransferase NAT10. Transcriptome-wide mapping of ac4C revealed discretely acetylated regions that were enriched within coding sequences. Ablation of NAT10 reduced ac4C detection at the mapped mRNA sites and was globally associated with target mRNA downregulation. Analysis of mRNA half-lives revealed a NAT10-dependent increase in stability in the cohort of acetylated mRNAs. mRNA acetylation was further demonstrated to enhance substrate translation in vitro and in vivo. Codon content analysis within ac4C peaks uncovered a biased representation of cytidine within wobble sites that was empirically determined to influence mRNA decoding efficiency. These findings expand the repertoire of mRNA modifications to include an acetylated residue and establish a role for ac4C in the regulation of mRNA translation.

Indexed as

Protein BiosynthesisAcetylationCytidineHeLa CellsHumansN-Terminal Acetyltransferase EN-Terminal AcetyltransferasesRNA, MessengerCytidineN-acetylcytidineNAT10 protein, humanN-Terminal Acetyltransferase EN-Terminal AcetyltransferasesRNA, MessengerepitranscriptomemRNA stabilitymRNA translationN4-acetylcytidineNAT10

Identifiers

PMID30449621
PMCPMC6295233
OpenAlexW2901932654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.